AGP Executive Report
Last update: 10 hours agoCancer Care Crisis: Hospitals across India report a shortage of key chemo drugs Cisplatin and Carboplatin, with some centres down to a day or two of supply—raising fears of treatment delays and worse outcomes. Patient Safety & Infection Control: The National Medical Commission tells medical colleges to tighten injection safety, banning reuse of needles/syringes and stressing hand hygiene and safe disposal to prevent HIV and viral hepatitis. Regulatory & Pharma Updates: Aurobindo Pharma gets final USFDA approval for Tofacitinib tablets (5mg/10mg), expanding its US generics portfolio; Wockhardt’s new injectable antibiotic Zaynich also gets FDA nod for drug-resistant UTI. Healthcare Workforce/Training: JSS AHER secures DASCA accreditation to strengthen data science and AI in health sciences. Medical Tourism Under Scrutiny: Delhi’s Malviya Nagar B&B fire probe details no ventilation, locked basement door and far more rooms than permitted; police FIR cites culpable homicide. Public Health Preparedness: Pune airport says Ebola preparedness measures are fully operational, with screening, self-declaration forms and referral protocols. Health Policy Politics: Tamil Nadu’s Opposition urges action to stop surrender of 152 super-speciality seats to the All-India Quota. Wellness & Research: Study suggests short calorie restriction before kidney donation may improve donor kidney protection markers.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
